Control group | Active group | p-value† | |
---|---|---|---|
HbA1c (%) | |||
Prior treatment | 8.18 ± 1.33 | 8.53 ± 1.29 | |
After treatment | 7.58 ± 1.06 | 7.39 ± 0.81 | |
p-value (baseline vs end)‡ | <0.001 | <0.001 | |
LS mean difference (95% CI) | 0.53 (0.31-0.76) | <0.001 | |
FBG (mg/dl) | |||
Prior treatment | 168.9 ± 47.2 | 182.6 ± 57.1 | |
After treatment | 148.5 ± 42.7 | 135.6 ± 34.5 | |
p-value(baseline vs end) ‡ | <0.001 | <0.001 | |
LS mean difference (95% CI) | 27.85 (15.74-39.95) | <0.001 |